Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


FOCAL SEGMENTAL GLOMERULOSCLEROSIS side effect

What is FOCAL SEGMENTAL GLOMERULOSCLEROSIS ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   FOCAL SEGMENTAL GLOMERULOSCLEROSIS and Recently Reported Side Effects   FOCAL SEGMENTAL GLOMERULOSCLEROSIS and 15 most Active Side Effect polls   FOCAL SEGMENTAL GLOMERULOSCLEROSIS and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with FOCAL SEGMENTAL GLOMERULOSCLEROSIS

ALENDRONATE  AVASTIN  CEREZYME  COLAZAL  EFFEXOR  IBUPROFEN  MIDOL  MYCOPHENOLATE  PROGRAF  RAPAMUNE  REMICADE  SIROLIMUS  SPRYCEL  


Avastin Side Effects Report #5660735-X
Health Professional from CANADA reported AVASTIN problem on Feb 25, 2008. Male patient, weighting 185.6 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, nephrotic syndrome, . AVASTIN dosage: 420 MG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID, IRINOTECAN. Patient recovered.

Prograf Side Effects Report #5635853-2
PROGRAF problem was reported by a Physician from BRAZIL on Feb 13, 2008. Female patient, child 8 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, proteinuria, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE, CORTICOSTEROIDS. Patient recovered.

Prograf Side Effects Report #5635855-6
Physician from BRAZIL reported PROGRAF problem on Feb 13, 2008. Female patient, child 10 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, proteinuria, . PROGRAF dosage: unknown. During the same period patient was treated with MYCONPHENOLATE, CORTICOSTEROIDS. Patient recovered.

Remicade Side Effects Report #5585064-4
REMICADE problem was reported by a Physician from UNITED STATES on Jan 02, 2008. Male patient, weighting 200.0 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, hypertension, . REMICADE dosage: unknown. Patient recovered.


Ibuprofen Side Effects Report #5603424-X
Physician from NETHERLANDS reported IBUPROFEN problem on Jan 07, 2008. Female patient, 44 years of age, was diagnosed with dysmenorrhoea and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, haemolytic uraemic syndrome, thrombotic microangiopathy, vaginal haemorrhage, . IBUPROFEN dosage: unknown. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5578730-8
PROGRAF problem was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, 59 years of age, weighting 135.4 lb, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, nephrotic syndrome, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with PREDONININE, CELLCEPT, LAMIVUDINE, AMLODIPINE BESYLATE, URSO, RABEPRAZOLE, BAKTAR. Patient recovered.

Alendronate Side Effects Report #5760590-3
Consumer or non-health professional from UNITED STATES reported ALENDRONATE problem on May 23, 2008. Male patient, 48 years of age, was diagnosed with osteopenia and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, renal tubular atrophy, . ALENDRONATE dosage: 35 MG, WEEKLY. During the same period patient was treated with PREDNISONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, ENALAPRIL MALEATE, NIFEDIPINE. Patient recovered.

Sirolimus Side Effects Report #5742356-3
SIROLIMUS problem was reported by a Health Professional from UNITED STATES on May 12, 2008. Female patient, 47 years of age, was diagnosed with immunosuppression and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, . SIROLIMUS dosage: unknown. Patient recovered.

Sprycel Side Effects Report #5746370-3
Health Professional from ITALY reported SPRYCEL problem on May 19, 2008. Female patient, 46 years of age, weighting 154.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, proteinuria, . SPRYCEL dosage: CUMULATIVE DOSE - 5880 MG.. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.


Rapamune Side Effects Report #5708608-8
RAPAMUNE problem was reported by a Physician from UNITED STATES on Apr 09, 2008. Female patient, 64 years of age, was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, haemolytic uraemic syndrome, malignant melanoma, thrombotic thrombocytopenic purpura, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient recovered.

Cerezyme Side Effects Report #5635828-3
Consumer or non-health professional from EGYPT reported CEREZYME problem on Feb 09, 2008. Male patient, 31 years of age, weighting 130.1 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, focal segmental glomerulosclerosis, haemodialysis, haemoglobin decreased, nephritis interstitial, platelet count decreased, refusal of treatment by patient, renal failure chronic, renal tubular atrophy, . CEREZYME dosage: unknown. Patient was hospitalized. Patient died on 01/11/2008.

Prograf Side Effects Report #5635854-4
PROGRAF problem was reported by a Physician from BRAZIL on Feb 13, 2008. Female patient, 16 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal segmental glomerulosclerosis, proteinuria, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE. Patient recovered.

Ibuprofen Side Effects Report #5597108-4
Health Professional from NETHERLANDS reported IBUPROFEN problem on Jan 08, 2008. Female patient, 44 years of age, was diagnosed with dysmenorrhoea and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: anaemia, focal segmental glomerulosclerosis, haemolytic uraemic syndrome, overdose, thrombotic microangiopathy, vaginal haemorrhage, . IBUPROFEN dosage: EIGHT 400 MG TABLETS ON 1 DAY. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5613349-1
PROGRAF problem was reported by a Physician from CANADA on Jan 22, 2008. Female patient, 48 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal segmental glomerulosclerosis, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE. Patient recovered.


Sirolimus Side Effects Report #5555047-9
Physician from UNITED STATES reported SIROLIMUS problem on Dec 03, 2007. Male patient, 51 years of age, was diagnosed with focal segmental glomerulosclerosis and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, focal segmental glomerulosclerosis, . SIROLIMUS dosage: unknown. Patient recovered.

Sirolimus Side Effects Report #5571593-6
SIROLIMUS problem was reported by a Physician from BELGIUM on Dec 20, 2007. Male patient, 43 years of age, weighting 172.0 lb, was diagnosed with prophylaxis against transplant rejection and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal segmental glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with DACLIZUMAB, TACROLIMUS. Patient was hospitalized. Patient recovered.

Sirolimus Side Effects Report #5574571-6
Physician from BELGIUM reported SIROLIMUS problem on Dec 20, 2007. Male patient, 43 years of age, weighting 172.0 lb, was diagnosed with prophylaxis against transplant rejection and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal segmental glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with DACLIZUMAB, TACROLIMUS. Patient was hospitalized. Patient recovered.

Effexor Side Effects Report #5586244-4
EFFEXOR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Female patient was diagnosed with anxiety and was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: focal segmental glomerulosclerosis, headache, hypertension, renal impairment, . EFFEXOR dosage: 225 MG 1X PER 1 DAY ; TAPERED OFF. During the same period patient was treated with ZOLOFT, DEXATRIM. Patient recovered.

Colazal Side Effects Report #5527965-9
Physician from UNITED STATES reported COLAZAL problem on Nov 15, 2007. Male patient, 33 years of age, weighting 183.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: dehydration, focal segmental glomerulosclerosis, hypertensive nephropathy, nephritis interstitial, renal failure acute, renal tubular necrosis, . COLAZAL dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PRIMAL DEFENSE, PREDNISONE, MECLIZINE. Patient was hospitalized and became disabled. Patient recovered.


Prograf Side Effects Report #5533933-3
PROGRAF problem was reported by a Physician from JAPAN on Nov 13, 2007. Female patient, child 10 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal segmental glomerulosclerosis, kidney rupture, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE. Patient recovered.

Ibuprofen Side Effects Report #5505244-3
Physician from NETHERLANDS reported IBUPROFEN problem on Oct 17, 2007. Female patient, 44 years of age, was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, focal segmental glomerulosclerosis, haemolytic uraemic syndrome, incorrect dose administered, laboratory test abnormal, thrombotic microangiopathy, vaginal haemorrhage, . IBUPROFEN dosage: 3200 MG (400 MG, 8 IN 1 D). Patient was hospitalized. Patient recovered.

Mycophenolate Side Effects Report #5643317-5
MYCOPHENOLATE MOFETIL problem was reported by a Consumer or non-health professional from JAPAN on Feb 18, 2008. Male patient, 16 years of age, was diagnosed with renal transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: cyst drainage, disease recurrence, focal segmental glomerulosclerosis, lymphocele, nephropathy toxic, proteinuria, renal impairment, ureteric obstruction, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIMULECT, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Mycophenolate Side Effects Report #5643331-X
Consumer or non-health professional from JAPAN reported MYCOPHENOLATE MOFETIL problem on Feb 18, 2008. Male patient, 16 years of age, was diagnosed with renal transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: cyst drainage, disease recurrence, focal segmental glomerulosclerosis, lymphocele, nephropathy toxic, proteinuria, renal impairment, ureteric obstruction, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIMULECT, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Ibuprofen Side Effects Report #5565892-1
IBUPROFEN problem was reported by a Health Professional from NETHERLANDS on Nov 30, 2007. Female patient, 44 years of age, was diagnosed with dysmenorrhoea and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: anaemia, blood lactate dehydrogenase increased, focal segmental glomerulosclerosis, haemolytic uraemic syndrome, thrombocytopenia, thrombotic microangiopathy, . IBUPROFEN dosage: 400 MG 8X/DAY ORAL (DF ORAL). Patient was hospitalized. Patient recovered.

Midol Side Effects Report #5764646-0
Consumer or non-health professional from UNITED STATES reported MIDOL problem on May 27, 2008. Female patient, 39 years of age, weighting 216.1 lb, was diagnosed with dysmenorrhoea, renal transplant and was treated with MIDOL. After drug was administered, patient experienced the following problems/side effects: adenomyosis, dysmenorrhoea, focal segmental glomerulosclerosis, renal failure chronic, transient ischaemic attack, . MIDOL dosage: unknown. During the same period patient was treated with ALEVE, PAMPRIN, NARCOTIC PAIN RELIVER, TYLENOL. Patient was hospitalized. Patient recovered.

Midol Side Effects Report #5767669-0
MIDOL problem was reported by a Consumer or non-health professional from UNITED STATES on May 27, 2008. Female patient, 39 years of age, weighting 216.1 lb, was diagnosed with dysmenorrhoea, renal transplant and was treated with MIDOL. After drug was administered, patient experienced the following problems/side effects: adenomyosis, dysmenorrhoea, focal segmental glomerulosclerosis, renal failure chronic, transient ischaemic attack, . MIDOL dosage: unknown. During the same period patient was treated with ALEVE, PAMPRIN, NARCOTIC PAIN RELIVER, TYLENOL. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about FOCAL SEGMENTAL GLOMERULOSCLEROSIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about FOCAL SEGMENTAL GLOMERULOSCLEROSIS